Research to Innovation: IPRs on Route to Commercialization

Tarih: 20.03.2018
Yer: Biyomedikal Mühendisliği Enstitüsü, AZ-19,   Boğaziçi Üniversitesi Kandilli Kampüsü, İstanbul

Omer HIZIROGLU
Managing Partner, TLS.IP

20 March 2018 (Tuesday);   13.00 – 14.00 

Biomedical Engineering Institute, AZ-19,  
Boğaziçi University Kandilli Campus
 

About The Seminar:

IPRs (intellectual Property rights) play a critical role in translating critical research into products and devices we use every day. In order to accelerate lab to market of life sciences innovations, proper understanding and management of key IP elements and their commercial impact and implications is important for researchers and R&D companies alike.

About the Speaker

Omer HIZIROGLU was a senior partner with Diffusion Capital Partners (DCP), an early stage technology investment fund of 35 million Euros based in Amsterdam. Previously, he was the General Manager of Inovent, Technology Transfer Fund of Sabanci University, first of its kind in the country. He is a founding member of the Galata Business Angels Network (GBA) first Angel Network in Turkey and past vice-president and a Board Member of LES International. BA in Economics and International Relations from Tufts University, LL.M from University of Lausanne and a Juris Doctor (J.D.) degree from Suffolk University. Member of Istanbul, New York and Massachusetts bars. Omer was named among IAM World’s 300 Leading IP Strategists, 2015, 2016 and 2017. Omer is a Certified Licensing Professional (CLP) and holds an expert level accreditation from European Knowledge Transfer Society (EuKTS).